Drugmakers pause Facebook ads for Juneteenth, joining anti-racism protest

Facebook mobile
Pharma companies joined a coalition of brands that halted Facebook ads to protest its lax racism policies. (Pixabay)

Pharma brands joined the #StopHateForProfit call to boycott Facebook advertising for Juneteenth and through the weekend. The call to action from civil rights organizations began last week with an ad in the Los Angeles Times asking advertisers to pause ads on Facebook during July in response to the social media platform’s history that allows “racist, violent and verifiably false content to run rampant on its platform.”

Nineteen pharma brands paused their Facebook ad campaigns on June 19, according to data gathered by AdComplyRx. Another 23 pharma product brands went dark for the entire weekend, said Ian Orekondy, CEO of AdComplyRx.

Three of the top 10 brands in the U.S.—Amgen, AbbVie and Novartis—went dark across their entire portfolio of brands for the entire weekend, hitting pause on advertising products such as Mavyret, Imbruvica and Cosentyx, respectively. Other pharma companies, such as Takeda, Merck, AstraZeneca, Pfizer and Gilead, paused one or more of their brands on June 19 or for the weekend. Juneteenth is celebrated on June 19 to honor the emancipation of slaves in the U.S.

Featured Webinar

How to Streamline Your Clinical Research Organization's Processes End to End

Learn how implementing one platform leads to data consistency and ultimately facilitate faster clinical trials while reducing overall trial costs, leave behind spreadsheets and home-grown tools for a predictable trial and the ability to forecast unit delivery resulting in the optics you need to ensure a successful trial, and hear experts share industry trends of what is affecting the Clinical Research Organization industry today.

RELATED: Pharma search ads shift to 'savings' and 'coverage' amid COVID-19 pandemic

“It appears to be a decision at the brand manager level as opposed to a decision by the pharma companies overall,” Orekondy said, adding that his company’s data back that up: Half of the top 10 companies paused one or more product brands, but not all of them did.

Several ad agencies confirmed to Orekondy that the pause requests came through brand managers on specific products.

One of those agencies, Good Apple, confirmed that several of its pharma brands had joined the movement this weekend. An agency spokesperson for the digital social media agency said via email that the response was similar to the 2017 boycott of advertising on YouTube after the platform declined to stop posting ads next to extremist content. That boycott garnered widespread pharma company support.

“Similar to 2017, we anticipate a number of large advertisers in the pharma space to participate or address the movement,” the spokesperson said. “Good Apple is expecting this boycott to gain more traction than the one against YouTube and is in the process of scenario planning for clients, inclusive of reallocating funds from Facebook to other channels. "

RELATED: Bayer, Pfizer top pharma on social media, but everyone could be doing better: report

While the agency believes the movement will continue to grow, still to be determined is exactly which pharma companies will participate. Already more consumer brands this week, including Patagonia, committed to the original July ad boycott call from six civil rights organizations: the Anti-Defamation League, the NAACP, Sleeping Giants, Color Of Change, Free Press and Common Sense.

Suggested Articles

Three facts about how distributors are managing in-demand inventory.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.

Purdue has reached an $8 billion settlement with the U.S. government to settle criminal and civil charges for its role in the U.S. opioid crisis.